IP Library Granted Patent US 6,884,877
Granted Patent B2
US 6,884,877 · App. 10/264,303 · Granted Apr 26, 2005

Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods

Assignee: Florida State University Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,884,877
App. No.
10/264,303
Granted
Apr 26, 2005
Kind
B2
Abstract

Disclosed are major allergenic proteins in cashew nut, which are legumin-like proteins and 2S albumins. Also disclosed is a polypeptide allergen in the 7S superfamily, which includes vicilin-like and sucrose binding proteins. Several linear epitopes of the cashew nut are identified and characterized. The invention further discloses the sequence of cDNA encoding the allergenic polypeptide, the allergen being designated Ana o 1, and also describes the characterization of the expressed recombinant polypeptide and associated methods employing the polypeptide.

Claims (11)

1. An isolated nucleic acid comprising a sequence that encodes a cashew polypeptide containing a linear IgE epitope having the amino acid sequence of SEQ ID NO:3.

2. An isolated nucleic acid comprising a sequence that encodes a cashew polypeptide containing a linear IgE epitope having the amino acid sequence of SEQ ID NO:4.

3. An isolated nucleic acid comprising a sequence that encodes a cashew polypeptide containing one or more IgE epitopes having at least one amino acid sequence selected from SEQ ID NO:5-15.

4. An isolated nucleic acid sequence comprising the nucleotide sequence of SEQ ID NO: 1 for a cashew polypeptide containing a linear IgE epitope.

5. The nucleic acid sequence of claim 4 , wherein SEQ ID NO:1 further comprises at least one mutation selected from a deletion, a substitution, and an addition.

6. An expression vector comprising the nucleic acid sequence of claim 4 operably linked to an expression control sequence.

7. A cultured cell comprising the vector of claim 6 .

8. A cultured cell transfected with the vector of claim 6 , or a progeny of said cell, wherein the cell expression a polypeptide encoded by said nucleic acid sequence.

9. A cultured cell comprising the nucleic acid sequence of claim 4 , operably linked to an expression control sequence.

10. A method of producing a protein, comprising culturing the cell of claim 9 under conditions permitting expression of a polypeptide encoded by said nucleic acid.

11. The method of claim 10 further comprising purifying the polypeptide from the cell or the medium of the cell.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2015
From: ROUX, KENNETH; SATHE, SHRIDHAR
To: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 037174/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2015
From: TEUBER, SUZANNE S.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 037175/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2003
From: TEUBER, SUZANNE S.
To: ROGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 014216/0376 →
Continuity (3)
Provisional Application 6037177400 · Apr 11, 2002
Provisional Application 6032679300 · Oct 3, 2001
Related Publication 20030124060A1 · Jul 3, 2003